Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments

Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments

Cancer has been the leading cause of mortalities, with lung cancer contributing 18% to overall deaths. Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. The primary form of therapy used to treat lung cancer still includes oral and systemic administration of drugs, radiot...

Full description

Bibliographic Details
Main Authors: Chetna Gupta, Aadya Jaipuria, Nikesh Gupta
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
inhalation
pulmonary delivery
lung cancer
dry-powder inhalers
nanomedicines
Online Access:https://www.mdpi.com/1999-4923/15/1/139

Internet

https://www.mdpi.com/1999-4923/15/1/139

Similar Items